Loading...
Clinical significance of CD73 in triple-negative breast cancer: multiplex analysis of a phase III clinical trial
BACKGROUND: CD73 is an ecto-enzyme that promotes tumor immune escape through the production of immunosuppressive extracellular adenosine in the tumor microenvironment. Several CD73 inhibitors and adenosine receptor antagonists are being evaluated in phase I clinical trials. PATIENTS AND METHODS: Ful...
Na minha lista:
| Udgivet i: | Ann Oncol |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Oxford University Press
2018
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5913595/ https://ncbi.nlm.nih.gov/pubmed/29145561 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/annonc/mdx730 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|